↓ Skip to main content

Monalizumab: inhibiting the novel immune checkpoint NKG2A

Overview of attention for article published in Journal for Immunotherapy of Cancer, October 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

news
1 news outlet
twitter
27 X users
wikipedia
1 Wikipedia page

Citations

dimensions_citation
182 Dimensions

Readers on

mendeley
175 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Monalizumab: inhibiting the novel immune checkpoint NKG2A
Published in
Journal for Immunotherapy of Cancer, October 2019
DOI 10.1186/s40425-019-0761-3
Pubmed ID
Authors

Thorbald van Hall, Pascale André, Amir Horowitz, Dan Fu Ruan, Linda Borst, Robert Zerbib, Emilie Narni-Mancinelli, Sjoerd H. van der Burg, Eric Vivier

X Demographics

X Demographics

The data shown below were collected from the profiles of 27 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 175 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 175 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 25 14%
Researcher 25 14%
Student > Master 22 13%
Student > Bachelor 22 13%
Other 6 3%
Other 18 10%
Unknown 57 33%
Readers by discipline Count As %
Immunology and Microbiology 35 20%
Biochemistry, Genetics and Molecular Biology 31 18%
Medicine and Dentistry 20 11%
Agricultural and Biological Sciences 15 9%
Pharmacology, Toxicology and Pharmaceutical Science 4 2%
Other 16 9%
Unknown 54 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 24. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 October 2021.
All research outputs
#1,587,734
of 25,559,053 outputs
Outputs from Journal for Immunotherapy of Cancer
#403
of 3,459 outputs
Outputs of similar age
#33,965
of 369,565 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#12
of 99 outputs
Altmetric has tracked 25,559,053 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,459 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.7. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 369,565 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 99 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.